The deck is stacked against the avg Andres...Just trying to beat the odds.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He won't respond... there's nothing he can say... no defense. He'll just move on to rehash another baseless attack.
I agree.
Why would a journal wait on/for approval.
WTF do you mean they couldn't finish a single trial?! What company creates a desperately needed drug for a fatal disease without pursuing patent protections!
What a dumb@zz comment.
The way I see it, Merck must immediately buy (or partner with) NWBO before their $17 billion wonder drug is made worthless (by NWBO merely using someone else's). This Combo patent is NWBO's coup d'etat on cancer AND on Big Pharma's control over it's treatment... but what do i know.
Hear! Hear!
Exactly right, Bright Boy...
BS. Trial finish.
I Agree...
I am not breaking out the Boones Farm (lol) or partying yet... but I am excited because (1) the trial is done (preliminary results were released), (2) manufacturing is in place & scalable and (3) The combo-patent will force BP to engage with NWBO via partnership or buyout.
Everyone who has held NWBO throughout all of the bs that has occurred over the years, when we had little evidence DCVAX worked (while Phase5, AF and others constantly talked trash), should be excited, imo.
This is a real-life David vs Goliath story of which I am privileged to be part.
That says it all! Thanks for the reminder.
Hear! Hear!
I have been invested in NWBO since about 2013. I have NEVER been more excited about my investment prospects as I am now.
Thanks for your comments. Excellent post!
That may be the case but wtf can be automated after DCVAX has been made?
(not directed at you).
Perhaps DI can clarify.
I hope he has been put on notice... but don't think he can help himself.
Agreed...
I hope I didn't jump the gun here... let me review.
I watched the Brexit debates and have been saying it ever since.
When NWBO rockets to the stratosphere, I'll stop using "Hear! Hear!" and use "Ordaah!" (i.e. Order!) to calm long-time longs down, lol.
I love watching British debates.
The application has been submitted but the license will not be implemented/received until AFTER approval. This is my assumption... could be wrong.
My focus was that approval is very near!
Adam is irrelevant to NWBO's future... which is why LP ignores him.
That is my take too.
Here's the exact wording from the email (Bold/red emphasis added for emphasis):
Yes. We don't know when approval will come... but LP, via her actions, is sure approval will occur, imo.
Trocprofit,
We just learned from this morning's PR that "An automated system for the fill and finish of DCVax-L product has also been delivered, installed, validated and qualified". The email stated,
Sorry Gus, I have no idea. I'm too excited about the following para from the PR release this morning:
An automated system for the fill and finish of DCVax-L product has also been delivered, installed, validated and qualified. “Fill and finish” is the final step of the process, after a batch of DCVax-L product has been manufactured, in which the batch is allocated into single doses in individual vials for cryopreservation and distribution.
Just received this email. Does this sound like the imminent failure of the DCVax-L trial? LMAO!
Dear William,
We are pleased to send you our most recent release regarding further progress made at our Sawston, UK facility. Northwest Biotherapeutics has announced that an application for a manufacturing license for commercial manufacturing of cellular therapies (after the therapies receive regulatory approval) has been submitted to the regulatory authorities. This manufacturing license is separate from any application for approval of DCVax-L itself.
Best,
Dave Innes
VP, Investor Relations
Northwest Bio?therapeutics, Inc.
Oh, boy. I didn't think about that. I'll do better next time. Don't want to give anyone a heart attack. GLTU
God damn it, NWBO trial was a failure, right? LMAO!
Northwest Biotherapeutics Announces Filing of Application for License for Commercial Manufacturing at Sawston, UK Facility
Press Release | 07/06/2022
https://www.otcmarkets.com/stock/NWBO/news?id=363861
I can definitely see that.
AF will still attack NWBO AFTER even after the journal article. Look at AMRN. He will have no impact after the journal article.
Exactly...
I hold a different point of view.
Though I understand and respect yours, nothing/no one can convince me that updating the trial data/endpoints was an oversight, that somehow this ivy-league trained lawyer-- who taught medical product development and commercialization (and-- I think, if memory serves me correctly-- merger and acquisitions at some point too) for more than six years at the National Institutes of Health and at Georgetown Law School as an adjunct professor-- forgot to update the data given all the bullshit her enemies have done to thwart her efforts. That conclusion would, imo, be untenable.
More than everyone on this board, combined, LP has a vested interest to succeed. She isn't incompetent nor does she lack knowledge of what she is doing. The likely "problem" (from some investor's pov) is DCVax-L is changing the treatment of all cancers. Powerful entities could lose huge fortunes while some could gain fortunes. Some are likely jockeying for position. Others are wreaking havoc to thwart or slow down the inevitable. LP is majoring on the majors, sort of speak, dealing with issues that can derail her main objectives... not the day-to-day stock swing bullshit.
Some of us may be uncomfortable with the silence. But you can bet your sweet @zz, LP is not silent behind the scenes... but what do I know?
https://nwbio.com/company-management/#:~:text=Linda%20F.,Powers&text=Powers%20has%20served%20as%20the,therapies%2C%20from%202001%20to%202010.
Incorrect! These people would have attacked NWBO no matter what. If they didn't have a reason, they would have made one up. Remember Phase5? Came out of nowhere dropped a damning report and a few months later disappeared to never be seen again. Had NWBO updated the clincialtrial.gov website they would have said NWBO changed the data endpoints after-the-fact and added some additional bs.
These people will hit NWBO with everything they have until they can't-- journal article. But enough data is out (to the extent that we KNOW DCVAX-L works) that we, imo, should be more at ease than ever before with our investment in NWBO. Yet, based on posts, many are not. Go figure.
NWBO won, period. NO OTHER TREATMENT PRODUCED THESE RESULTS IN THE LAST DECADE OR TWO (ALMOST THREE) for GBM!
The complete success of NWBO is not absolutely guaranteed, but as of May 10th (based on the data) the risk is very, very low compared to what it was in any period in the past.
Approval/commercialization is, imo, a formality.
That is THE billion $$$ question. She isn't incompetent and damn sure isn't stupid. There are only a few explanations now that we KNOW DCVAX-L works, imo.
Exactly...